相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Etiologic heterogeneity of clear-cell and papillary renal cell carcinoma in the Netherlands Cohort Study
Jeroen A. A. van de Pol et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
The effect of partial nephrectomy on blood pressure in patients with solitary kidney
Nikhil Gupta et al.
WORLD JOURNAL OF UROLOGY (2021)
Changes in blood pressure during treatment with the tyrosine kinase inhibitor lenvatinib
Kei Saito et al.
CLINICAL KIDNEY JOURNAL (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Impact of Concomitant Cardiovascular Medication on Survival of Metastatic Renal Cell Carcinoma Patients Treated with Sunitinib or Pazopanib in the First Line
Ondrej Fiala et al.
TARGETED ONCOLOGY (2021)
Antihypertensive medications are associated with the risk of kidney and bladder cancer: a systematic review and meta-analysis
Yuxiu Xie et al.
AGING-US (2020)
Incidence and Risk Factors of Hypertension Following Partial Nephrectomy in Patients With Renal Tumors: A Cross-sectional Study of Postoperative Home Blood Pressure and Antihypertensive Medications
Hiroshi Fukushima et al.
CLINICAL GENITOURINARY CANCER (2020)
Hypertension management in cardio-oncology
Hani Essa et al.
JOURNAL OF HUMAN HYPERTENSION (2020)
Polyarteritis Nodosa: an unusual case of paraneoplastic process in renal cell carcinoma
Umair Ahmed et al.
JOURNAL OF COMMUNITY HOSPITAL INTERNAL MEDICINE PERSPECTIVES (2020)
Vascular Cardio-Oncology: Vascular Endothelial Growth Factor inhibitors and hypertension
Jorie Versmissen et al.
CARDIOVASCULAR RESEARCH (2019)
European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update
Borje Ljungberg et al.
EUROPEAN UROLOGY (2019)
Real-world treatment patterns and adverse events in metastatic renal cell carcinoma from a large US claims database
Sumanta Pal et al.
BMC CANCER (2019)
Cancer treatment and survivorship statistics, 2019
Kimberly D. Miller et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Association between blood pressure and risk of cancer development: a systematic review and meta-analysis of observational studies
Aristeidis Seretis et al.
SCIENTIFIC REPORTS (2019)
Hypertension as a prognostic factor in metastatic renal cell carcinoma treated with tyrosine kinase inhibitors: a systematic review and meta-analysis
Yu Liu et al.
BMC UROLOGY (2019)
Drug-Induced Hypertension Caused by Multikinase Inhibitors (Sorafenib, Sunitinib, Lenvatinib and Axitinib) in Renal Cell Carcinoma Treatment
Nanna Baek Moller et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
A 10-Year Old Girl with Resistant Hypertension without Significant Indication of an Underlying Renal Cell Carcinoma, Misdiagnosed as Malaria
Olarinde Jeffrey Ogunmola et al.
AMERICAN JOURNAL OF CASE REPORTS (2019)
Hypertension in Cancer Patients and Survivors Epidemiology, Diagnosis, and Management
Jordana B. Cohen et al.
JACC: CARDIOONCOLOGY (2019)
Management of Adverse Events Associated with Cabozantinib Therapy in Renal Cell Carcinoma
Manuela Schmidinger et al.
ONCOLOGIST (2018)
Impact of Estrogen on the Relationship Between Obesity and Renal Cell Carcinoma Risk in Women
Lijiang Sun et al.
EBIOMEDICINE (2018)
Prevention and Control of Hypertension JACC Health Promotion Series
Robert M. Carey et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
The association between BMI and kidney cancer risk An updated dose-response meta-analysis in accordance with PRISMA guideline
Xuezhen Liu et al.
MEDICINE (2018)
Renin angiotensin system deregulation as renal cancer risk factor (Review)
Pawel Sobczuk et al.
ONCOLOGY LETTERS (2017)
Angiotensin Inhibitors as Treatment of Sunitinib/Pazopanib-induced Hypertension in Metastatic Renal Cell Carcinoma
Patrick Penttila et al.
CLINICAL GENITOURINARY CANCER (2017)
Antihypertensive medication use and risk of renal cell carcinoma
Joanne S. Colt et al.
CANCER CAUSES & CONTROL (2017)
Therapy of Treatment-Related Hypertension in Metastatic Renal-Cell Cancer Patients Receiving Sunitinib
Philipp Ivanyi et al.
CLINICAL GENITOURINARY CANCER (2017)
Incidence of Cardiovascular Events after Nephrectomy - A Single Centre, Matched Pair Analysis between Donor and Tumour Nephrectomy in a Long Term Follow-Up
Sebastian Nestler et al.
UROLOGIA INTERNATIONALIS (2016)
Hypertension and angiotensin system inhibitors in patients with metastatic renal cell carcinoma
Lisa Derosa et al.
ONCOLOGY REVIEWS (2016)
Nephron-sparing Techniques Independently Decrease the Risk of Cardiovascular Events Relative to Radical Nephrectomy in Patients with a T1a-T1b Renal Mass and Normal Preoperative Renal Function
Umberto Capitanio et al.
EUROPEAN UROLOGY (2015)
Progression of hypertension after partial nephrectomy in patients with renal tumors: A preliminary report
Masaharu Inoue et al.
INTERNATIONAL JOURNAL OF UROLOGY (2015)
Therapeutic effects and associated adverse events of multikinase inhibitors in metastatic renal cell carcinoma: A meta-analysis
Qinxiang Tan et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2015)
Should we use the angiotensin-converting enzyme inhibitors for the treatment of anti-VEGF-induced hypertension?
G. Emile et al.
ANNALS OF ONCOLOGY (2014)
Arterial hypertension and cancer
Alberto Milan et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Reduced Risk of Incident Kidney Cancer from Walking and Running
Paul T. Williams
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE (2014)
Targeting interleukin-6 in inflammatory autoimmune diseases and cancers
Xin Yao et al.
PHARMACOLOGY & THERAPEUTICS (2014)
Predictive factor and antihypertensive usage of tyrosine kinase inhibitor-induced hypertension in kidney cancer patients
Kouji Izumi et al.
ONCOLOGY LETTERS (2014)
Resistance Training Controls Arterial Blood Pressure in Rats with L-NAME-Induced Hypertension
Ayslan Jorge Santos de Araujo et al.
ARQUIVOS BRASILEIROS DE CARDIOLOGIA (2013)
The association between physical activity and renal cancer: systematic review and meta-analysis
G. Behrens et al.
BRITISH JOURNAL OF CANCER (2013)
Physical Activity and the Prevention of Hypertension
Keith M. Diaz et al.
CURRENT HYPERTENSION REPORTS (2013)
An investigation of risk factors for renal cell carcinoma by histologic subtype in two case-control studies
Mark P. Purdue et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Preventive role of exercise training in autonomic, hemodynamic, and metabolic parameters in rats under high risk of metabolic syndrome development
Ivana Cinthya Moraes-Silva et al.
JOURNAL OF APPLIED PHYSIOLOGY (2013)
Hypertension in adolescence is not an independent risk factor for renal cancer: A cohort study of 918,965 males
Adi Leiba et al.
JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION (2013)
Body Mass Index and Renal Cell Cancer The Influence of Race and Sex
Jennifer L. Beebe-Dimmer et al.
EPIDEMIOLOGY (2012)
Page Kidney: Etiology, Renal Function Outcomes and Risk for Future Hypertension
Andrew Smyth et al.
JOURNAL OF CLINICAL HYPERTENSION (2012)
Effects of Partial Nephrectomy on Postoperative Blood Pressure
Nathan Lawrentschuk et al.
KOREAN JOURNAL OF UROLOGY (2012)
Adverse events from targeted therapies in advanced renal cell carcinoma: the impact on long-term use
Ziya Kirkali
BJU INTERNATIONAL (2011)
Use of angiotensin-converting-enzyme inhibitors or angiotensin-receptor blockers and cancer risk: a meta-analysis of observational studies
Chan Yoon et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2011)
Toxicities of Targeted Therapy and Their Management in Kidney Cancer
Giuseppe Di Lorenzo et al.
EUROPEAN UROLOGY (2011)
Toxicity as a Biomarker of Efficacy of Molecular Targeted Therapies: Focus on EGFR and VEGF Inhibiting Anticancer Drugs
Rodrigo Dienstmann et al.
ONCOLOGIST (2011)
Body Mass Index and Subsequent Risk of Kidney Cancer: A Prospective Cohort Study in Japan
Norie Sawada et al.
ANNALS OF EPIDEMIOLOGY (2010)
Cigarette Smoking and Hypertension
A. Virdis et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Initial Assessment, Surveillance, and Management of Blood Pressure in Patients Receiving Vascular Endothelial Growth Factor Signaling Pathway Inhibitors
Michael L. Maitland et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Epidemiology and risk factors for kidney cancer
Wong-Ho Chow et al.
NATURE REVIEWS UROLOGY (2010)
Cardiovascular toxicity following sunitinib therapy in metastatic renal cell carcinoma: a multicenter analysis
G. Di Lorenzo et al.
ANNALS OF ONCOLOGY (2009)
Tolerability of first-line therapy for metastatic renal cell carcinoma
Camillo Porta et al.
CANCER TREATMENT REVIEWS (2009)
Obesity and renal cell carcinoma: epidemiology, underlying mechanisms and management considerations
Zachary Klinghoffer et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2009)
Toxicity associated with the long-term use of targeted therapies in patients with advanced renal cell carcinoma
Dale R. Shepard et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2009)
Angiotensin II Type 1 Receptor Antagonist as an Angiogenic Inhibitor in Urogenital Cancer
Akira Miyajima et al.
REVIEWS ON RECENT CLINICAL TRIALS (2009)
Physical activity during adulthood and adolescence in relation to renal cell cancer
Steven C. Moore et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
Blood pressure and risk of renal cell carcinoma in the european prospective investigation into cancer and nutrition
Steffen Weikert et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
Cardiac Toxicity of Sunitinib and Sorafenib in Patients With Metastatic Renal Cell Carcinoma
Manuela Schmidinger et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Adverse renal consequences of obesity
Karen A. Griffin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2008)
Hypertension, Antihypertensive Therapy and Renal-Cell Cancer: A Meta-Analysis
Giovanni Corrao et al.
CURRENT DRUG SAFETY (2007)
Change in circadian rhythm of blood pressure by bilateral radical nephrectomy and haemodialysis: a case report
T. Uzu et al.
JOURNAL OF HUMAN HYPERTENSION (2006)
Lipid peroxidation and renal cell carcinoma: Further supportive evidence and new mechanistic insights
M Gago-Dominguez et al.
FREE RADICAL BIOLOGY AND MEDICINE (2006)
Hypertension, antihypertensives and mutations in the Von Hippel-Lindau gene in renal cell carcinoma: results from the Netherlands Cohort Study
Leo J. Schouten et al.
JOURNAL OF HYPERTENSION (2005)
Renal cell carcinoma in relation to cigarette smoking: Meta-analysis of 24 studies
JD Hunt et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Active and passive smoking and risk of renal cell carcinoma in Canada
JF Hu et al.
EUROPEAN JOURNAL OF CANCER (2005)
Biology and clinical development of vascular endothelial growth factor-targeted therapy in renal cell carcinoma
BI Rini et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Antihypertensive therapy and the risk of malignancies
E Grossman et al.
EUROPEAN HEART JOURNAL (2001)
Obesity, hypertension, and the risk of kidney cancer in men.
WH Chow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
